Your session is about to expire
← Back to Search
Behavioral Intervention
REACHOUT Mental Health Support App for Type 1 Diabetes
N/A
Waitlist Available
Led By Tricia S Tang, PhD
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Have type 1 diabetes (T1D)
Be 19 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0, 3, 6 month(s)
Awards & highlights
Study Summary
This trial investigates if a 6-month mental health support program, delivered via a mobile app, helps adults with type 1 diabetes. Features include 24/7 chat, virtual happy hours, and trained Peer-Supporters.
Who is the study for?
This trial is for adults over 19 with type 1 diabetes who live in certain areas of British Columbia, speak English, and experience some distress related to their diabetes. They must have internet or smartphone access. Those with pre-existing mental health conditions or substance use issues cannot participate.Check my eligibility
What is being tested?
The study tests a mobile app called REACHOUT that offers peer-led mental health support to adults with type 1 diabetes. Participants will use the app's features like chat rooms and virtual happy hours for six months, compared to a wait-list group.See study design
What are the potential side effects?
Since this trial involves a support program rather than medication, traditional side effects are not expected. However, participants may experience emotional discomfort or privacy concerns while using the app.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have type 1 diabetes.
Select...
I am 19 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 0, 3, 6 month(s)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0, 3, 6 month(s)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Diabetes Distress
Secondary outcome measures
Change in % Time in Range
Change in Depressive Symptom Severity
Change in Diabetes-Specific Quality of Life
+6 moreTrial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: REACHOUTExperimental Treatment1 Intervention
The REACHOUT intervention arm will receive access to the REACHOUT mobile app through which they will be able to review profiles of Peer Supporters and connect with one of their choosing. They will also have access to the other app features including a 24/7 chat room and face-to-face support via virtual happy hours. Participants will complete questionnaires (baseline, 1 month, 3 months, 6 months) and a blood draw (baseline and 6 months). Monetary compensation will be provided for their time and effort.
Group II: Wait-listActive Control1 Intervention
The wait-list control group will receive access to the mobile app/support program after six (6) months. They will complete questionnaires and a blood draw at baseline and 6 months. Monetary compensation will be provided for their time and effort.
Find a Location
Who is running the clinical trial?
Brain CanadaOTHER
17 Previous Clinical Trials
5,744 Total Patients Enrolled
Juvenile Diabetes Research FoundationOTHER
232 Previous Clinical Trials
141,529 Total Patients Enrolled
University of British ColumbiaLead Sponsor
1,413 Previous Clinical Trials
2,466,741 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have type 1 diabetes.Your average score on the diabetes distress scale is 2 or higher.I am 19 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Wait-list
- Group 2: REACHOUT
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any opportunities for individuals to participate in this trial at the present time?
"As per clinicaltrials.gov, this trial is not looking for participants at present. The original posting date was May 1st 2023 and the last edit was made on February 24th 2023. Despite this study's lack of recruitment, there are 380 other trials that require patient volunteers right now."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger